BMS-986256

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986256, covering 2025-02-06 to 2025-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants [Phase 1]

See pricing